How Nextyn Designed a GTM Strategy That Led to a Successful Drug Launch in Three Emerging Markets
Executive Summary
A biotech firm was preparing to launch a new pharmaceutical drug in emerging markets but faced challenges with regulatory approvals, distribution, and market awareness. The company lacked a structured Go-To-Market (GTM) strategy to effectively:
- Navigate regulatory landscapes for fast-track approvals.
- Establish strategic distribution partnerships with hospitals & pharmacies.
- Create awareness among physicians & healthcare professionals.
To ensure a successful launch, the biotech firm partnered with Nextyn’s Research & Consulting team. Over a six-month engagement, Nextyn executed:
- Regulatory research & approval planning for each target market.
- A distribution & partnership model for hospitals and healthcare providers.
- A medical marketing strategy, including physician outreach and patient education.
- A digital GTM strategy to reach doctors, patients, and industry stakeholders.
Outcome: The biotech firm successfully launched in three new markets, achieving $5M+ in sales within the first year.
Client Profile & Challenges
Client Profile:
- Industry: Biotechnology & Pharmaceuticals
- Project Focus: GTM Strategy for Drug Launch
- Target Audience: Physicians, healthcare institutions, patients
Challenges Faced by the Biotech Firm:
- Regulatory & Compliance Barriers: Each market had different approval timelines & compliance requirements.
- Limited Awareness Among Physicians & Healthcare Providers: The drug needed strong medical marketing for widespread adoption.
- Inefficient Distribution Model: The company lacked local partnerships with hospitals, pharmacies, and government healthcare agencies.
- Patient Education & Trust Issues: Patients were unfamiliar with the drug, leading to slow adoption.
Without a strong GTM strategy, the firm risked delays in approvals, poor market penetration, and low prescription rates.
Nextyn’s Solution
Regulatory Research & Approval Planning
Nextyn conducted a detailed regulatory landscape analysis for each target market:
- Mapped out fast-track approval pathways in collaboration with regulatory bodies.
- Developed submission strategies for FDA, EMA, and emerging market health authorities.
- Guided clinical trial compliance to meet regulatory standards.
Distribution & Hospital Partnership Strategy
- Identified top-tier hospitals & pharmacy chains for distribution partnerships.
- Developed a local sales & distribution network to streamline availability.
- Negotiated bulk procurement deals with healthcare institutions & insurance providers.
Medical Marketing & Physician Outreach Strategy
- Designed a physician education program to introduce the drug’s benefits.
- Hosted webinars & medical conferences featuring industry experts.
- Created a key opinion leader (KOL) network to influence prescription rates.
Patient Awareness & Digital Engagement Strategy
- Launched multilingual digital campaigns to educate patients & caregivers.
- Developed informational websites & mobile apps for prescription tracking.
- Collaborated with health influencers & NGOs to increase trust & adoption.
Impact & Results
- $5M+ in Sales Within Year 1: The drug achieved strong early market penetration.
- Regulatory Approvals Secured in 3 Countries: Nextyn’s compliance strategy ensured faster approval timelines.
- 20% Higher Prescription Rates in Target Hospitals: Physician engagement increased prescription adoption.
- 60% Increase in Patient Awareness & Trust: Digital marketing boosted patient education & engagement.
By leveraging Nextyn’s GTM consulting expertise, the biotech firm successfully launched in new markets with strong regulatory compliance, sales growth, and patient trust.
Why Nextyn?
- Proven Expertise in Pharmaceutical GTM Strategy & Market Entry
- Deep Understanding of Regulatory Approvals & Compliance Barriers
- Successful Track Record in Physician Outreach & Patient Awareness Campaigns
- Strong Industry Network for Hospital & Distribution Partnerships
